Live Interview
And why does that matter?
This is how a Mato agent talks. Take the other seat: answer a few and feel it follow the thread.
Podcast charts
Published by Linda Elsegood
Listen to LDN Prescribers, Researchers, Pharmacists from around the world discuss Low Dose Naltrexone. This is your chance to ask your questions to the experts, please email linda@ldnrt.org with your questions. The LDN Radio Show is FREE if you would like to make a donation please visit www.ldnresearchtrust.org/donate
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
The Mato Topic Intelligence Platform does not report this podcast as charting in a published category in this snapshot.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
Join host Linda Elsegood on the LDN Radio Show as she interviews Rachel, a woman with over 25 years of experience living with multiple sclerosis. Rachel shares her transformative journey with Low Dose Naltrexone (LDN), detailing significant symptom relief and medication reduction. Discover how LDN has positively impacted her life, addressing issues like double vision, spasticity, and incontinence.
This LDN Radio Show episode features Joyce Risa Kleinman sharing her daughter Jenni’s inspiring journey with ALS. Jenni, a naturopathic physician, found significant relief and extended quality of life through low-dose naltrexone (LDN) after her diagnosis. The discussion explores the challenges of LDN adoption in medicine and highlights Jenni’s remarkable resilience and advocacy.
Explore a personalized approach to Low-Dose Naltrexone (LDN) with Dr. JJ Allen on the LDN Radio Show. Discover his journey from engineering to pharmacy, advocating for foundational health, lifestyle changes, and evidence-based nutraceuticals. Learn about optimizing key nutrients and the nuanced titration of LDN for autoimmune conditions and long COVID.
This episode of the LDN Radio Show features Deborah sharing her journey with peripheral neuropathy and her positive experience using low-dose naltrexone (LDN). Host Linda Elsegood also discusses her own experiences with chronic pain conditions and the benefits of LDN. The conversation touches upon gut health, the FODMAP diet, and the challenges of accessing and raising awareness for LDN treatments.
This professional discussion explores the innovative microdosing protocol for Low Dose Naltrexone (LDN) developed by Dr. Norman Marcus. The conversation highlights its effectiveness in managing autoimmune diseases, cancers, and particularly Mast Cell Activation Syndrome (MCAS). Learn about the challenges and advancements in LDN therapy and its growing applications.
Join Linda Elsegood and Dr. Marina Straseck-Sury on the LDN Radio Show as they explore women's health, fertility, and lifestyle impacts. Dr. Straseck-Sury, an experienced OBGYN, shares her journey and insights into natural fertility solutions. Discover innovative therapies and essential health topics discussed in her new book, now available for pre-order on Amazon
Dr. Yusaf (PJ) Saleeby shares insights from his practice in 2025 regarding Low Dose Naltrexone (LDN). He discusses patient sensitivity, optimal starting doses, and LDN's efficacy for various conditions including Lyme, cancer, and autoimmune diseases. The conversation also delves into Mast Cell Activation Syndrome (MCAS) and the critical role of informed clinicians in its management.
Low dose naltrexone (LDN) offers potential benefits for various health issues. A Missie from the US shares her personal experience with LDN, highlighting her battles with chronic pain, autoimmune diseases, and a blood disorder. After initial scepticism, she notices significant health improvements, including better sleep and reduced pain. LDN helps reverse organ damage and improve her blood condition, emphasising the need for patience and openness to its benefits.
Pharmacist Dr. James Blackburn shares his journey in pharmacy and the significance of compounding. He discusses low-dose naltrexone (LDN) and its benefits for autoimmune diseases, mental health, and women's health. Insights on compounding practices, quality, and personal experiences with fertility and mental health challenges are highlighted. Dr. Blackburn emphasizes the importance of proper testing and lifestyle's impact on health, addressing the community's need for effective treatments.
Description Explore the profound impact of music therapy with Professor Lee Anna Rasar on the LDN Radio Show. Discover how adapted songs aid anger management, how harmonica playing enhances respiratory function, and how melodic intonation therapy assists stroke patients. Learn about music's role in sleep induction, dementia care, and Parkinson's gait training, showcasing its neuroscience-based approach. Book for the Live Zoom webinar, $20 including the recording With Lee Anna Rasar, Professor of Music Education/Therapy, titled “Dancing in the Rain: Music to Complement LDN.” for medical professionals and patients 28th April at 11:00 a.m. Central Time (5:00 p.m. UK Time). 1-hour presentation followed by a 1-hour live Q&A register at https://linktr.ee/ldnrt
Low dose naltrexone (LDN) shows promise in treating autoimmune diseases and cancers. Dr. Stephanie Werner shares insights on LDN's effectiveness in managing inflammation and enhancing patient outcomes, particularly in women's health issues like polycystic ovary syndrome and pregnancy challenges. The importance of diet and avoiding inflammatory foods is discussed, along with personal responsibility in healthcare and LDN's potential in managing chronic conditions.
Low-dose naltrexone (LDN) is highlighted as a supportive treatment in oncology, enhancing other therapies rather than acting alone. It helps regulate the immune system, calms microglia, and alleviates symptoms like pain and fatigue. LDN's low toxicity and potential to improve quality of life are emphasized, along with its evolving role in cancer therapies and immune modulation.
Low-dose naltrexone (LDN) is discussed as a treatment for chronic illnesses, focusing on its effectiveness and dosing protocols. Experts highlight the importance of collaboration among healthcare providers and the need for more research and awareness. They address misconceptions, potential insurance coverage, and share patient experiences, emphasizing personalized care in managing chronic conditions. The show invites further inquiries from the audience.
LDN treatment involves specific dosing strategies and patient experiences, particularly for conditions like multiple sclerosis and restless leg syndrome. Timing of medication is crucial, and the discussion highlights the rising prevalence of autism, potential links to environmental toxins, and dietary influences. Families face challenges in managing these conditions, emphasizing the need for ongoing communication between practitioners and patients as understanding of LDN's applications evolves.
Dr. Pamela Smith explores the benefits of low dose naltrexone (LDN) and therapeutic plasma exchange (TPE) for treating toxins and autoimmune diseases. She discusses the rising toxicity in patients and how combining TPE with LDN and nutrients can enhance health outcomes. The importance of personalized treatment plans and the role of inflammation in chronic diseases are highlighted, along with insights on managing medication tolerance and the need for ongoing research.
Dr. Phil Boyle explains how low-dose naltrexone can effectively treat infertility and recurrent miscarriage. He outlines the clinical criteria for its use and shares patient experiences. Maintaining treatment during pregnancy is crucial for better outcomes. The discussion also covers naltrexone's potential benefits for postpartum depression and the significance of endorphin levels in health. Dr. Boyle concludes with a mention of a new publication in restorative reproductive medicine.
Kallos from Napal shared her expereince of LDN and how it helped her get her life back. She has UCTD, Vitiligo and PCOS Kallos from Nepal shared her inspiring experience with Low-Dose Naltrexone (LDN) and how it has played a crucial role in helping her regain control of her life. Living with conditions such as Undifferentiated Connective Tissue Disease (UCTD), vitiligo, and Polycystic Ovary Syndrome (PCOS) had made daily life challenging for her. Before starting LDN, Kallos struggled with various symptoms that significantly impacted her quality of life, including fatigue, skin issues, and hormonal imbalances. However, after discussing her options with her healthcare provider, she decided to try LDN as a part of her treatment plan. Since incorporating LDN into her routine, she has noticed remarkable improvements in her overall well-being. Kallos feels more energetic, her skin condition has stabilized, and her symptoms of PCOS have become more manageable. She emphasizes how LDN has not only improved her physical health but has also positively affected her mental health, allowing her to engage more fully with her daily activities and reclaim her life.
Taran from the United States shares her journey with Ehlers-Danlos Syndrome (EDS) and Postural Orthostatic Tachycardia Syndrome (POTS), which began in 2015 when she suddenly passed out at work, becoming bedridden for six months. Despite being very active beforehand, she was left confused and distressed. After researching online and consulting with a cardiologist, Taran received diagnoses for POTS and EDS. For several years, they underwent a trial-and-error approach to treatment. In September 2024, Taran's mother discovered low-dose naltrexone (LDN) as a potential treatment, leading Taran to a primary care physician specializing in EDS. Nervously, she started LDN at a low dose and experienced significant pain and fatigue relief within days. After finding their optimal dose at 4.5 mg, Taran described the medication as a life-changing experience. Reflecting on her childhood, Taran recalls having eczema, random rashes, and food sensitivities, which went unnoticed due to their active lifestyle. Overall, she express gratitude for LDN and its impact on managing her symptoms.
Barb from Canada shares her 26-year journey with fibromyalgia, which began with chronic pain and a lengthy struggle for a diagnosis. Initially, she explored various treatments, including conventional medications like Oxycontin and alternative therapies, but found limited relief. After learning about Low Dose Naltrexone (LDN) from the fibromyalgia community, she sought a doctor willing to prescribe it. After changing family doctors, Barb encountered a new physician who did not believe in fibromyalgia and refused to prescribe LDN. However, through the LDN Research Trust, she found a supportive doctor who offered remote consultations. Since starting LDN in April, Barb experienced remarkable improvements in energy and quality of life within three weeks, allowing her to engage in activities she had long avoided. Her transformation has surprised both her and her family, leading others to inquire about her treatment.
Deb from Australia shared her journey with rheumatoid arthritis, which she experienced for about four years before receiving a proper diagnosis. Initially, her GP attributed her chronic pain to other issues and suggested topical treatments. A physio at Nambbor General Hospital recognized her symptoms and referred her to a rheumatologist, who confirmed the diagnosis through blood tests and MRIs. Deb was prescribed methotrexate and folic acid but sought an alternative due to her desire for a healthier lifestyle. She turned to low-dose naltrexone (LDN) upon her integrative GP's recommendation. After starting on LDN, she experienced nausea and dizziness but persevered. Eventually, she reached a dose of 4.5 mg and became completely pain-free, significantly improving her quality of life. Deb expressed gratitude for LDN and noted feelings of euphoria and a boost in her overall health. Although her rheumatologist advised her to continue methotrexate for potential bone erosion, Deb felt fantastic on LDN and is looking forward to her next appointment. Additionally, she mentioned her background as a social worker, her previous burnout, and the possibility that autoimmune conditions run in her family.
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed September 20, 2026. Cached outside the daily freshness window; the positions keep the date they were taken on.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.